✦ LIBER ✦

Dynamic tumor modeling of the dose–response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial

✍ Scribed by Andrew Stein, Wenping Wang, Alison A Carter, Ovidiu Chiparus, Norbert Hollaender, Hyewon Kim, Robert J Motzer, Celine Sarr

Book ID: 119897366
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 519 KB
Volume: 12
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-12-311

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

728 DYNAMIC TUMOR MODELLING OF THE RECOR

728 DYNAMIC TUMOR MODELLING OF THE RECORD-1 PHASE II TRIAL OF EVEROLIMUS QUANTIFIES RELATIONSHIP BETWEEN DOSE AND TUMOR GROWTH IN METASTATIC RENAL CELL CARCINOMA

✍ A. Stein; W. Wang; A. Carter; O. Chiparus; N. Hollaender; R. Motzer; C. Sarr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Phase 3 trial of everolimus for metastat

Phase 3 trial of everolimus for metastatic renal cell carcinoma : Final results and analysis of prognostic factors

✍ Robert J. Motzer; Bernard Escudier; Stephane Oudard; Thomas E. Hutson; Camillo P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

Tumor Growth Rate Provides Useful Inform

Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data

✍ Ferté, Charles; Koscielny, Serge; Albiges, Laurence; Rocher, Laurence; Soria, Je 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 694 KB

Re: Tumor Growth Rate Provides Useful In

Re: Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data

✍ Laguna, M. Pilar 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 61 KB